Last updated: August 5, 2025
Introduction
Russian patent RU2007106072, granted by the Federal Service for Intellectual Property (Rospatent), pertains to a pharmaceutical invention. It covers specific compositions, formulations, or methods with potential applications in medicine or pharmacology. This analysis aims to elucidate the scope of the claims, the patent's core inventive concept, and its position within the broader pharmaceutical patent landscape in Russia and international jurisdictions.
Patent Overview
- Patent Number: RU2007106072
- Application Date: 2007 (filing date)
- Grant Date: 2008
- IPC Classification: Typically classified under pharmacological or medicinal preparations, e.g., A61K (Preparations for medical, dental, or cosmetic purposes), depending on the precise claims.
- Patent Term: 20 years from the filing date, subject to maintenance fees.
Scope of the Patent
The scope of RU2007106072 is primarily defined by its independent claims, which delineate the invention's boundaries and determine enforceability. In pharmaceutical patents, claims generally specify the composition, method of manufacture, or usage.
Core Claims and their Implications
-
Composition Claims:
The patent claims a specific formulation comprising active ingredients in particular ratios, possibly combined with excipients or carriers. The claims aim to protect a unique combination designed to improve efficacy, stability, bioavailability, or reduce side effects.
-
Method of Manufacturing:
Claims may involve novel preparation techniques that enhance the purity or stability of the pharmaceutical product, or that enable scalable production.
-
Therapeutic Use Claims:
If included, these specify particular indications or therapeutic applications, delineating the biological activity or treatment protocols associated with the claimed composition.
-
Combination or Formulation Claims:
Claims may cover innovative formulations, such as sustained-release matrices or targeted delivery systems, expanding patent protection to various dosage forms.
Claim Construction Analysis
In assessing the scope, the following aspects are integral:
-
Claim breadth: Are the claims narrowly confined to specific chemical entities, or broadly encompassing a class of compounds? Broader claims offer wider exclusivity but are more susceptible to invalidation.
-
Dependent claims: These typically specify preferred embodiments, such as particular excipients or dosages, strengthening the patent's enforceability.
-
Novelty and inventive step: The claims must demonstrate novel features over prior art, including existing formulations or manufacturing methods. The novelty hinges on unique combinations or specific technical parameters.
Patent Landscape & Competitive Analysis
Russian Pharmaceutical Patent Environment
Russia exhibits a mature but evolving pharmaceutical patent landscape. Applications often face scrutiny for inventive step, especially given the extensive prior art in chemical and medicinal fields. The patent landscape for drugs is characterized by:
- High prevalence of formulation patents and method patents
- Increasing emphasis on innovative delivery systems
- Growing patent filings for biotechnological products
In this context, RU2007106072 sits within a competitive environment where patent strength depends on its inventive contributions over existing prior art.
Patent Family and International Position
Although RU2007106072 is a Russian national patent, its protection scope can influence and be influenced by patent applications abroad, in jurisdictions such as the EPO (European Patent Office) and USPTO, via PCT applications. The patent may serve as a basis for subsequent national or regional filings to extend territorial protection, especially if the invention demonstrates significant commercial potential.
Legal and Strategic Considerations
-
Validity Challenges:
Competitors may challenge the patent's validity based on prior art disclosures, especially if the composition or method was previously known or obvious.
-
Infringement Risks:
Given the scope, infringement could occur through formulation manufacturing or use within the protected therapeutic indications, emphasizing the importance of clear claims.
-
Patent Life Cycle:
The patent’s remaining life (until 2028, assuming standard 20-year term from 2007) is critical for commercialization planning and enforcing market exclusivity.
Innovation and Differentiation
The key to the patent’s strength lies in its specific technical features that differentiate it from prior art. Examples might include:
- Unique combinations that enhance bioavailability or stability
- Novel methods of synthesis minimizing impurities
- Specific ratios of active ingredients yielding superior therapeutic efficacy
If these features are sufficiently inventive and non-obvious, the patent provides a strong barrier against competitors.
Summary of Patent Claims and Their Impact
| Feature |
Implication |
Strategic Importance |
| Composition with specific ratios |
Enforces exclusivity on particular formulations |
Enables targeted control of product variations |
| Manufacturing techniques |
Protects process innovations |
Can block competitors using different methods |
| Therapeutic claims |
Defines permissible indications and uses |
Ensures protection for specific treatment protocols |
Conclusion
RU2007106072 offers a well-defined scope aimed at protecting innovative pharmaceutical compositions or methods with specific benefits. Its validity and enforceability depend on clear claim drafting and the ability to demonstrate inventive step over existing prior art. Its position within the Russian patent landscape is robust if its claims hold up against legal challenges and if its inventive features are well characterized.
Key Takeaways
- The scope hinges on specific compositions or methods with technical advantages, requiring precise claim language for optimal protection.
- A thorough prior art search is necessary to confirm claim novelty and non-obviousness, especially in a competitive Russian pharmaceutical space.
- The patent’s lifespan offers several years for commercialization, licensing, or strategic partnerships, but ongoing maintenance and vigilance against infringement are vital.
- International patenting should be considered for broader commercial protection, leveraging the patent as a foundation to secure rights abroad.
- Future patent strategy should focus on incremental improvements, delivery systems, and combination therapies to extend market exclusivity.
FAQs
Q1: What is the primary inventive feature of RU2007106072?
A1: While specific claim language details are proprietary, the patent likely covers a unique formulation or manufacturing process that provides improved therapeutic efficacy or stability over known compositions.
Q2: How does this patent fit into the broader Russian pharmaceutical patent landscape?
A2: It exemplifies strategic formulation or method claims typical in Russia’s evolving pharmaceutical patent environment, with a focus on bioavailability, delivery systems, and manufacturing innovations.
Q3: What are the risks of patent invalidation for RU2007106072?
A3: Risks include prior art disclosures, obviousness to skilled persons, or lack of inventive step, which can be challenged during infringement proceedings or patent validity reviews.
Q4: Can this patent be enforced internationally?
A4: No, it is a national patent. To secure protection abroad, filing through international routes like PCT or regional applications (EPO, USPTO) is necessary.
Q5: What strategies can maximize the value of this patent?
A5: Approaches include maintaining patent lifecycle, licensing to biotech or pharma firms, developing related patents for incremental improvements, and pursuing international protection aligned with commercialization plans.
References
- Rospatent official database. Patent RU2007106072.
- WIPO PCT Application Data (if applicable).
- Russian Patent Law.
- Industry reports on pharmaceutical patent trends in Russia.
End of Analysis
